Recently, significantly increased levels of nicotinamide phosphoribosyl‐transferase (NAMPT) and NAMPT‐AS at mRNA and protein expression levels were detected in serum, small EVs, and tumor tissues of CRC patients and associated with poor survival, suggesting a possible involvement of these molecules in CRC pathogenesis [20]. The gene discussed is NAMPT; the disease is neoplasm.